A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder - Wikidata - awgldk - TriplyDB

A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder

A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder

http://www.wikidata.org/entity/Q30498105

about

Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders A review of obsessive-compulsive disorder in children and adolescents The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment Pharmacotherapy for anxiety disorders in children and adolescents Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials Improving Outcome of Psychosocial Treatments by Enhancing Memory and Learning.The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders Pharmacological enhancement of fear reduction: preclinical models.Testing the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans.Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.Novel approaches in treatment of pediatric anxiety.D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive-Compulsive Disorder?A novel treatment for tinnitus and tinnitus-related cognitive difficulties using computer-based cognitive training and D-cycloserine Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways.Evidence-based pharmacotherapy of obsessive-compulsive disorder.D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders.Cognitive enhancers for anxiety disorders.Looking beyond Fear and Extinction Learning: Considering Novel Treatment Targets for Anxiety.MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome Glutamatergic agents for OCD and related disorders Fear extinction and BDNF: translating animal models of PTSD to the clinic.Attention bias modification treatment augmenting effects on cognitive behavioral therapy in children with anxiety: randomized controlled trial.D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis.Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders Obsessive-compulsive disorder: Evidence-based treatments and future directions for research Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.The Leyton Obsessional Inventory-Child Version Survey Form does not demonstrate adequate psychometric properties in American youth with pediatric obsessive-compulsive disorder.Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress The Efficacy of Augment of D-Cycloserine and Cognitive-behavioral Therapy on Adolescent with one Type of Anxiety Disorders: A Double-blind Randomized Controlled Trial Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond.Glutamate-based anxiolytic ligands in clinical trials.

P2860

Q22242989-E57B6317-FB2F-4A63-8DD1-B4F177A4C780 Q24187995-7B437EF9-EAD5-43A7-8758-158CC0F5BADD Q24604879-83ADB3D2-D0A4-4CF3-9285-C2C2E3D92DE5 Q24605193-B2399E71-0D0C-4A99-BC95-B8EBDC6AD1A8 Q24633004-28247636-2D71-49F1-B798-9F60F56CE896 Q26853715-EFACDF7D-CE04-45E5-9719-BABB5A2979BE Q27006437-C9834EC1-2FC5-4A6C-8A99-FD09B0BD6B7B Q27009995-9285AC51-54FC-4937-9A4C-6018CF01CEB0 Q30375098-FE3A523D-3B4F-4D5F-BD65-98C95060387F Q30417837-B538D56D-7451-41DE-93D3-9207375B78FF Q30426498-2309B092-E729-4AC5-A197-E50F70339927 Q30462825-094D4E9E-C72E-4713-8245-884A31E1BF2D Q30525198-4D07EB12-132F-4553-822B-E5E6BCA287F0 Q31171981-3E4DEB04-8385-423B-933A-95CC85B5F4A9 Q33598320-B0994019-5FF6-403D-8BB1-F2FE1CDF4C52 Q33760626-42362168-D7A3-48E3-8AE1-28B22D5EBDE1 Q33835384-C39B1445-435A-49AB-9262-87DC86B9912C Q33912531-BFF0E720-D5F8-4FDD-BA13-22D0E1E96864 Q34017493-2349FA08-D087-4AB3-B1BF-9B49CA7F5E98 Q34090048-B04A387F-B0E7-47D9-95D7-5FC3C24C087E Q34245428-625F8158-B1BF-42BA-B03B-339A508AFE60 Q34350942-E3D1ADC0-DCEE-473F-A428-12F9AFADA854 Q35043125-C49F6ABB-1216-47A5-A2FF-B57FC34040C1 Q35098882-65CF43CF-B2C1-48B4-B9DD-D97C3930DD9C Q35130440-753E42B2-04B0-467F-B99A-A5AA3C75224F Q35541703-0474A835-2395-430B-8F55-05505D2AE3EB Q35679478-42CBE85A-0FFB-46BF-AAF8-A150498315B5 Q35967025-F8808BB8-D495-4CD0-9AFA-3959AE88CF48 Q36074354-5533F815-22CE-46E5-A3CB-B523DEB67BB0 Q36237977-C49B54E8-07DF-4846-BC40-852B834B55FF Q36304362-DE86FE23-3592-4BE5-9F9E-962428089B6D Q36764528-55E63494-9938-4048-A5A8-2E9390EFD039 Q36873932-2AC352AB-FC8D-4E3D-AE43-E4C67ACACB6F Q37195340-08537619-F6E4-452F-AD3A-B53A291F257B Q37257029-69FE5FAA-7526-4F23-9B4C-C8DF8EE9CF50 Q37257053-C02A4B45-9FFA-4DB5-A79B-7E7089F6BF41 Q37667486-CEAABBA4-6859-4C62-8D24-4BBC338371CB Q37690425-36E032A8-4AB3-4E57-8439-AB36EE0E3585 Q38057736-B356CCCC-FF13-4671-8614-33F3754C1607 Q38110306-50875B75-FE39-42D2-87A1-6AF602B3F998

P2860

A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder

http://www.wikidata.org/entity/Q30498105

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A preliminary study of D-cyclo ...... obsessive-compulsive disorder

@ast

A preliminary study of D-cyclo ...... obsessive-compulsive disorder

@en

type

label

A preliminary study of D-cyclo ...... obsessive-compulsive disorder

@ast

A preliminary study of D-cyclo ...... obsessive-compulsive disorder

@en

prefLabel

A preliminary study of D-cyclo ...... obsessive-compulsive disorder

@ast

A preliminary study of D-cyclo ...... obsessive-compulsive disorder

@en

P1433

Q30498105-D40126AB-F19E-48E2-8747-67E56D1DF726

P1476

Q30498105-9C99E252-2C26-405F-8AFE-62972F9CF0DB

P2093

Q30498105-0A7D6B5C-ADF4-4904-8D99-48334FA23C3A

Q30498105-324EBCB8-7058-4A7A-A823-267A7D02878B

Q30498105-50D9B69E-E76A-4036-84FC-E9EE886B7F65

Q30498105-5205D865-020F-4CCC-83CD-0CD7E5B25DF0

Q30498105-87BB82AE-CD09-478C-AC2B-766DE9C119D2

Q30498105-A033E73B-8125-4F3A-872B-E776897F5D6B

Q30498105-A3DFF69D-7667-488E-B5AF-8885745D8987

Q30498105-A5E2E9AE-D57D-4675-8953-E3B672D5CB36

Q30498105-B8D91C27-C9D1-4EDD-866C-3750B4D1290A

Q30498105-DB3670A6-8DC3-401F-8041-63F84091349B

P2860

Q30498105-0392AA50-CC92-4F75-80D9-2BF5316C9D54

Q30498105-0FD84559-625C-482F-A660-BD76047629B6

Q30498105-25F51E3A-C2AF-4CCE-AC1D-7C375D84BBAD

Q30498105-43311139-5BD1-496E-9B30-DE551C386C26

Q30498105-4B7D945D-4673-449D-8C8B-EAEF551CFAB9

Q30498105-6AA66764-99C6-411F-89AF-5FE5D4187194

Q30498105-6EEB96E0-D0ED-45F2-BCA4-8138A39D3A7E

Q30498105-6EFDC533-ED5C-47B1-9B41-B49A8307A202

Q30498105-763B4E69-1E94-4F04-A189-D28648A71EF5

Q30498105-8570B2B4-D333-461E-B45D-59D62BB761DE

P304

Q30498105-CBDF93C2-9AE6-4EAD-B17F-138A2AC2F0E9

P31

Q30498105-D654EECC-F227-494E-A666-075AE9D5F8A8

P356

Q30498105-B8FAA4CD-6054-41E7-8863-2F747A1CD18D

P407

Q30498105-D8A7267F-277B-4E1A-AA7D-ED51DBF030A1

P433

Q30498105-7C6BC2EE-4373-4791-B9A2-0085787DD33A

P478

Q30498105-026E22D8-D70B-460B-A47B-67F3CD1FA516

P577

Q30498105-4171FE47-8897-4868-80D4-A8816D603873

P5875

Q30498105-6C9D8F20-B1D5-4133-86D8-BC368EF8C43E

P698

Q30498105-B140D1F3-39F7-43F6-AE98-2981F5A672EB

P932

Q30498105-1034EB82-FEBE-41F4-BE93-8A7AC2DFF81B

P356

J.BIOPSYCH.2010.07.015

P1433

Biological Psychiatry

P1476

A preliminary study of D-cyclo ...... obsessive-compulsive disorder

@en

P2093

Adam B Lewin

http://www.w3.org/2001/XMLSchema#string

Aude Henin

http://www.w3.org/2001/XMLSchema#string

Daniel A Geller

http://www.w3.org/2001/XMLSchema#string

Eric A Storch

http://www.w3.org/2001/XMLSchema#string

Gary R Geffken

http://www.w3.org/2001/XMLSchema#string

Jamie A Micco

http://www.w3.org/2001/XMLSchema#string

Michael Bengtson

http://www.w3.org/2001/XMLSchema#string

Sabine Wilhelm

http://www.w3.org/2001/XMLSchema#string

Susan Sprich

http://www.w3.org/2001/XMLSchema#string

Tanya K Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

The epidemiology of obsessive-compulsive disorder in children and adolescents.

Role of norepinephrine in the pathophysiology and treatment of mood disorders.

Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity.

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.

Effects of D-cycloserine on extinction: translation from preclinical to clinical work.

P304

1073-1076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2010.07.015

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46148516

http://www.w3.org/2001/XMLSchema#string

P698

20817153

http://www.w3.org/2001/XMLSchema#string

P932

3034091

http://www.w3.org/2001/XMLSchema#string